Effect of Ensifentrine Treatment on CAT Score

NCT06460493 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: Ensifentrine 3 mg twice daily

Sponsor

Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA

Collaborators

[object Object]